"For more than 50 years, CTVS has been proud to offer Central Texas the most specialized and innovative cardiothoracic and vascular surgical care available. As cardiothoracic and vascular surgeons, we specialize in surgery of the heart, lungs, chest, esophagus and major blood vessels of the body. Our state-of-the-art treatment options, comprehensive care and 24-hour availability provide our patients the ability to return as quickly as possible to good health. The most sophisticated diagnostic and surgical techniques are provided by CTVS surgeons from all Central Texas area hospitals."

During the past decade, Cardiothoracic and Vascular Surgeons conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 9 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiothoracic and Vascular Surgeons" #1 sponsor was "W.L.Gore & Associates" with 5 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "C. R. Bard" with 3 trials sponsored, "Bolton Medical" with 2 trials sponsored and "Silk Road Medical" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiothoracic and Vascular Surgeons" #1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator, "Libra Medical" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Cardiothoracic and Vascular Surgeons" are "Peripheral Arterial Disease" (5 trials), "Carotid Artery Disease" (3 trials), "Abdominal Aortic Aneurysm" (2 trials), "Aortic Aneurysm, Thoracic" (2 trials) and "Peripheral Artery Disease" (2 trials). Many other conditions were trialed in "Cardiothoracic and Vascular Surgeons" in a lesser frequency.

Most popular intervention types in "Cardiothoracic and Vascular Surgeons" are "Device" (26 trials), "Procedure" (4 trials), "Other" (2 trials), "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "GORE® TAG® Thoracic Branch Endoprosthesis" (2 trials), "AFX EVAR AAA Graft System" (1 trials), "BioMimics 3D Vascular Stent System" (1 trials), "Carotid Stenting (CAS)" (1 trials) and "Carotid WALLSTENT Monorail Endoprosthesis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiothoracic and Vascular Surgeons" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Cardiothoracic and Vascular Surgeons". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Cardiothoracic and Vascular Surgeons, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiothoracic and Vascular Surgeons, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".